Clinical Trial Update: S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

View source ↗

Summary

This completed clinical trial investigated whether biomarkers can predict outcomes in postmenopausal women with hormone receptor-positive, node-positive breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• FLUOROURACIL (Fluorouracil)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Status: COMPLETED